Literature DB >> 27585063

Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis .

Pengzi Zhang1, Jing Lu1, Yali Jing1, Sunyinyan Tang1, Dalong Zhu1, Yan Bi1.   

Abstract

Diabetic foot is a severe public health issue, yet rare studies investigated its global epidemiology. Here we performed a systematic review and meta-analysis through searching PubMed, EMBASE, ISI Web of science, and Cochrane database. We found that that global diabetic foot ulcer prevalence was 6.3% (95%CI: 5.4-7.3%), which was higher in males (4.5%, 95%CI: 3.7-5.2%) than in females (3.5%, 95%CI: 2.8-4.2%), and higher in type 2 diabetic patients (6.4%, 95%CI: 4.6-8.1%) than in type 1 diabetics (5.5%, 95%CI: 3.2-7.7%). North America had the highest prevalence (13.0%, 95%CI: 10.0-15.9%), Oceania had the lowest (3.0%, 95% CI: 0.9-5.0%), and the prevalence in Asia, Europe, and Africa were 5.5% (95%CI: 4.6-6.4%), 5.1% (95%CI: 4.1-6.0%), and 7.2% (95%CI: 5.1-9.3%), respectively. Australia has the lowest (1.5%, 95%CI: 0.7-2.4%) and Belgium has the highest prevalence (16.6%, 95%CI: 10.7-22.4%), followed by Canada (14.8%, 95%CI: 9.4-20.1%) and USA (13.0%, 95%CI: 8.3-17.7%). The patients with diabetic foot ulcer were older, had a lower body mass index, longer diabetic duration, and had more hypertension, diabetic retinopathy, and smoking history than patients without diabetic foot ulceration. Our results provide suggestions for policy makers in deciding preventing strategy of diabetic foot ulceration in the future. Key messages Global prevalence of diabetic foot is 6.3% (95%CI: 5.4-7.3%), and the prevalence in North America, Asia, Europe, Africa and Oceania was 13.0% (95%CI: 10.0-15.9%), 5.5% (95%CI: 4.6-6.4%), 5.1% (95%CI: 4.1-6.0%), 7.2% (95%CI: 5.1-9.3%), and 3.0% (95% CI: 0.9-5.0%). Diabetic foot was more prevalent in males than in females, and more prevalent in type 2 diabetic foot patients than in type 1 diabetic foot patients. The patients with diabetic foot were older, had a lower body mass index, longer diabetic duration, and had more hypertension, diabetic retinopathy, and smoking history than patients without diabetic foot.

Entities:  

Keywords:  Diabetic foot; epidemiology; global; prevalence

Mesh:

Year:  2016        PMID: 27585063     DOI: 10.1080/07853890.2016.1231932

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  208 in total

1.  Autologous platelet-rich gel combined with in vitro amplification of bone marrow mesenchymal stem cell transplantation to treat the diabetic foot ulcer: a case report.

Authors:  Qinan Wu; Xiaotian Lei; Liu Chen; Yanling Zheng; Hongmei Huang; Cheng Qian; Ziwen Liang
Journal:  Ann Transl Med       Date:  2018-08

2.  Adipose-derived mesenchymal stem cells accelerate diabetic wound healing in a similar fashion as bone marrow-derived cells.

Authors:  Jianming Guo; Haidi Hu; Jolanta Gorecka; Hualong Bai; Hao He; Roland Assi; Toshihiko Isaji; Tun Wang; Ocean Setia; Lara Lopes; Yongquan Gu; Alan Dardik
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-07       Impact factor: 4.249

3.  Reflections on the effects of nitric oxide produced by a new dressing in the local management of diabetic foot ulcers.

Authors:  Yolanda García-Álvarez; José Luis Lázaro-Martínez; Raúl Juan Molines-Barroso
Journal:  Ann Transl Med       Date:  2018-12

4.  Association between Osteoprotegerin and Charcot Neuroarthropathy: a systematic review.

Authors:  Renata Ochoa-Précoma; Blanca T Pacheco-Soto; Leonardo M Porchia; Enrique Torres-Rasgado; Ricardo Pérez-Fuentes; M Elba Gonzalez-Mejia
Journal:  Acta Diabetol       Date:  2021-01-04       Impact factor: 4.280

Review 5.  The use of fat grafting and platelet-rich plasma for wound healing: A review of the current evidence.

Authors:  Oliver J Smith; Gavin Jell; Ash Mosahebi
Journal:  Int Wound J       Date:  2018-11-20       Impact factor: 3.315

6.  Fat grafting and platelet-rich plasma for the treatment of diabetic foot ulcers: A feasibility-randomised controlled trial.

Authors:  Oliver J Smith; Richard Leigh; Muholan Kanapathy; Peter Macneal; Gavin Jell; Nadine Hachach-Haram; Haroon Mann; Ash Mosahebi
Journal:  Int Wound J       Date:  2020-07-07       Impact factor: 3.315

7.  Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Br J Clin Pharmacol       Date:  2018-01-05       Impact factor: 4.335

8.  Remote Temperature Monitoring in Patients With Visual Impairment Due to Diabetes Mellitus: A Proposed Improvement to Current Standard of Care for Prevention of Diabetic Foot Ulcers.

Authors:  Amanda L Killeen; Kara M Brock; James F Dancho; Jodi L Walters
Journal:  J Diabetes Sci Technol       Date:  2019-05-23

9.  [Chronic leg ulcers in older patients].

Authors:  N Duschek; F Trautinger
Journal:  Z Gerontol Geriatr       Date:  2019-06-11       Impact factor: 1.281

10.  Hospitalists' Needs Assessment and Perceived Barriers in Wound Care Management: A Quality Improvement Project.

Authors:  Cynthia A Walker; Alphonsa Rahman; Trina L Gipson-Jones; Ché Matthew Harris
Journal:  J Wound Ostomy Continence Nurs       Date:  2019 Mar/Apr       Impact factor: 1.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.